Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179595 · ClinicalTrials.gov registry record · Phase 2
Does the Relaxation Response Inhibit Acute Stress?
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT00179595 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 140 participants.
The verdict
NCT00179595, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purposes of this study are: 1. To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults. 2. To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative practice and those with no experience in meditation. Since stress is a factor in the development of many health conditions, a further understanding of the mechanisms of the RR should be developed. The project is designed to determine how the RR can improve the quality of life that has been adversely affected by stress.
Interventions
- BEHAVIORAL relaxation response- meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2002-05 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179595
The ClinicalTrials.gov registry entry for NCT00179595 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which relaxation response- meditation is the first listed.
NCT00179595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179595 about?
NCT00179595 is a clinical study titled "Does the Relaxation Response Inhibit Acute Stress?". The purposes of this study are: 1. To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults. 2. To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative p...
What is the current status of trial NCT00179595?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2002-05. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00179595?
The interventions under investigation include: relaxation response- meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00179595?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.